A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

Please provide your email address to receive an email when new articles are posted on . Both 0.03% and 0.05% atropine eyedrops significantly enlarged pupil size. Low-dose atropine drops had no ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

Atropine prescriptions in children with myopia did not increase ocular complication risks compared to non-users, despite myopia's inherent risks. The study involved over 1.2 million children, with 67% ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. One presenter said there is sufficient evidence ...

Treating U.S. children with an investigational low-dose (0.01%) formulation of atropine eye drops didn't delay worsening of nearsightedness, a randomized clinical trial found. Over 24 months, kids ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

The short-term use of atropine eye drops to treat myopia in children did not affect long-term visual outcomes, the prospective observational ATLAS study of participants from two randomized trials ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.